216 related articles for article (PubMed ID: 29431255)
1. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations.
Mack JM; Richter GT; Becton D; Salem O; Hill SEM; Crary SE
Pediatr Blood Cancer; 2018 Jun; 65(6):e27008. PubMed ID: 29431255
[TBL] [Abstract][Full Text] [Related]
2. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
Songsaeng D; Churojana A; Khumthong R; Mahiwan L
J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
[TBL] [Abstract][Full Text] [Related]
3. Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: A safe and effective treatment option.
Gregory S; Burrows PE; Ellinas H; Stadler M; Chun RH
Int J Pediatr Otorhinolaryngol; 2018 May; 108():30-34. PubMed ID: 29605361
[TBL] [Abstract][Full Text] [Related]
4. Intralesional bleomycin injection in management of low flow vascular malformations in children.
Mohan AT; Adams S; Adams K; Hudson DA
J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
[TBL] [Abstract][Full Text] [Related]
5. Single center experience with intralesional bleomycin sclerotherapy for lymphatic malformations.
Yılmaz H; Yılmaz Ö; Çamlıdağ İ; Belet Ü; Akan H
Jpn J Radiol; 2017 Oct; 35(10):590-596. PubMed ID: 28779454
[TBL] [Abstract][Full Text] [Related]
6. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.
Bothra N; Panda L; Sheth J; Tripathy D
Eye (Lond); 2018 Jan; 32(1):152-155. PubMed ID: 28776595
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
Hassan Y; Osman AK; Altyeb A
Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
[TBL] [Abstract][Full Text] [Related]
8. Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement.
Horbach SER; van de Ven JS; Nieuwkerk PT; Spuls PI; van der Horst CMAM; Reekers JA
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1494-1504. PubMed ID: 29948003
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations.
Mack JM; Peterson EC; Crary SE; Moran JH; Neville K; Pierce CD; Richter GT
Pediatr Blood Cancer; 2022 Aug; 69(8):e29733. PubMed ID: 35484878
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.
Shigematsu T; Sorscher M; Dier EC; Berenstein A
J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body.
Wohlgemuth WA; Müller-Wille R; Meyer L; Wildgruber M; Guntau M; Heydt SV; Pech M; Zanasi A; Flöther L; Brill R
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):731-739. PubMed ID: 33045393
[TBL] [Abstract][Full Text] [Related]
12. Treatment of deep-seated palatal vascular malformations by bleomycin sclerotherapy.
Agarwal R; Agarwal M; Agarwal D; Chandra R; Prasad R
J Plast Reconstr Aesthet Surg; 2021 Sep; 74(9):2272-2278. PubMed ID: 33531209
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin Electrosclerotherapy Treatment in the Management of Vascular Malformations.
Kostusiak M; Murugan S; Muir T
Dermatol Surg; 2022 Jan; 48(1):67-71. PubMed ID: 34608081
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic malformations compromising the upper airway in children: ultrasound-guided intralesional focal sclerotherapy with bleomycin targeting culprit lesions.
Usui H; Shinkai M; Kitagawa N; Mochizuki K; Kawakita I; Tsuzuki Y; Shinohara S; Yagi Y; Masuda M
Pediatr Surg Int; 2020 Sep; 36(9):1047-1054. PubMed ID: 32661596
[TBL] [Abstract][Full Text] [Related]
15. Foamed bleomycin sclerosis of airway venous malformations: The role of interspecialty collaboration.
Azene E; Mitchell S; Radvany M; Agrawal N; Eisele D; Weiss C
Laryngoscope; 2016 Dec; 126(12):2726-2732. PubMed ID: 27437862
[TBL] [Abstract][Full Text] [Related]
16. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.
Yang WH; Xiang XJ; Li HL
Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342
[TBL] [Abstract][Full Text] [Related]
17. Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations.
Milbar HC; Jeon H; Ward MA; Mitchell SE; Weiss CR; Cohen BA
J Vasc Interv Radiol; 2019 Sep; 30(9):1438-1442. PubMed ID: 30956080
[TBL] [Abstract][Full Text] [Related]
18. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series.
Ahmad S; Akhtar FK
Phlebology; 2019 Jun; 34(5):355-361. PubMed ID: 30336759
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.
Oomen KP; Paramasivam S; Waner M; Niimi Y; Fifi JT; Berenstein A; O TM
Laryngoscope; 2016 Jan; 126(1):205-11. PubMed ID: 25970858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
